For scientists and clinicians, its an excellent candidate for further study
Here's what you should know going in: Commonly reported effects include nausea, vomiting, diarrhea, and constipation, particularly during initial dose escalation Warnings and precautions in the prescribing information for applicable semaglutide and tirzepatide products cover pancreatitis, gallbladder disease, and kidney injury associated with volume depletion If you're on insulin or sulfonylureas, discuss hypoglycemia risk with your prescriber - GLP-1 medications can affect blood sugar control when combined with those drugs These medications slow gastric emptying, which can affect how orally taken medications are absorbed - worth flagging if you take other oral drugs regularly Certain FDA-approved semaglutide and tirzepatide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents
Duration of Each Session: Each treatment session generally takes about 30 to 45 minutes
A retrospective observational study published in Clinical Nutrition found that nutritional deficiencies were diagnosed in 12.7% of patients within 6 months of starting GLP-1 receptor agonists, and that number climbed to 22.4% within 12 months
Preventing pain at the base of the skull often involves lifestyle adjustments and ergonomic considerations
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL